<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03378557</url>
  </required_header>
  <id_info>
    <org_study_id>PPFx</org_study_id>
    <nct_id>NCT03378557</nct_id>
  </id_info>
  <brief_title>Periprosthetic Fracture Registry (PPFx)</brief_title>
  <acronym>PPFx</acronym>
  <official_title>Multicenter Prospective Registry for Periprosthetic Fractures After Hip or Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AO Innovation Translation Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AO Innovation Translation Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This registry supports international data collection and research on PPFx treatments after&#xD;
      hip and knee arthroplasty.&#xD;
&#xD;
      A registry such as this ultimately aims to provide far-reaching benefits to society including&#xD;
      reduced morbidity and mortality, improved patient safety, improved quality of care and&#xD;
      medical decision-making, reduced medical spending, and advances in orthopaedic science.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To close the gap of missing clinical evidence regarding the treatment of periprosthetic&#xD;
      fractures after arthroplasty of the hip or the knee with osteosynthesis.&#xD;
&#xD;
      To drive further study hypotheses and to answer unforeseen questions.&#xD;
&#xD;
      Main questions to be answered by the registry include (but are not exclusive) the following:&#xD;
&#xD;
        1. Influence of implants on outcome&#xD;
&#xD;
        2. Influence of surgical techniques on outcome&#xD;
&#xD;
        3. Influence of bone grafting on outcome&#xD;
&#xD;
        4. Identification of risk factors for failure&#xD;
&#xD;
        5. Identification of postoperative rehabilitation programs and its possible influence on&#xD;
           the outcome&#xD;
&#xD;
        6. Influence of fracture type on outcome&#xD;
&#xD;
        7. To serve as a comparative dataset for future studies with improved implants and&#xD;
           techniques&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 31, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Classification of the fracture</measure>
    <time_frame>Pre-operatively (Day -1)</time_frame>
    <description>Classification of the fracture using the UCS and some parts of the AO/OTA fracture classification system.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fracture mechanism</measure>
    <time_frame>Pre-operatively (Day -1)</time_frame>
    <description>High / low energy trauma, pathological fracture, stem stability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehabilitation program</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>weight bearing, bedrest, splint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Function of hip or knee</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Harris Hip Score or Knee Society score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>PROMIS pain interference and physical activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fracture healing</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>by RUSH or RUST score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain visual analog scale (VAS) and pain medication</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Using the pain visual analog scale (VAS) and pain medication</description>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Periprosthetic Fractures</condition>
  <condition>Periprosthetic Fracture Around Prosthetic Joint Implant</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with total or hemi hip or knee arthroplasty and who have a fracture around one of&#xD;
        the arthroplasty&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥18 years&#xD;
&#xD;
               -  Post-operative PPFx after total or hemi hip or total or unicondylar knee&#xD;
                  arthroplasty (including the acetabulum, femur, patella and proximal tibia)&#xD;
                  requiring&#xD;
&#xD;
                    -  osteosynthesis alone or&#xD;
&#xD;
                    -  component revision plus plate/nail osteosynthesis&#xD;
&#xD;
               -  Informed consent obtained, i.e.:&#xD;
&#xD;
                    -  Ability of the patient or assigned representative to understand the content&#xD;
                       of the patient information / Informed Consent Form&#xD;
&#xD;
                    -  Signed and dated EC / IRB approved written informed consent&#xD;
&#xD;
               -  Ability to attend post-operative follow up visits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or women planning to conceive within the study period&#xD;
&#xD;
          -  Prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl Stoffel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Baselland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brigitte Gallo, PhD</last_name>
    <phone>+41 44 200 24 06</phone>
    <email>Brigitte.Gallo@aofoundation.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zsofia Molnar</last_name>
    <phone>+41 44 200 24 78</phone>
    <email>Zsofia.molnar@aofoundation.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kantonspital Baselland</name>
      <address>
        <city>Liestal</city>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Stoffel, MD</last_name>
      <phone>+41 (0) 61 436 36 36</phone>
      <email>Karl.Stoffel@ksbl.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Periprosthetic Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

